Skip to main content

Christie to mass-produce Care222 far-UVC disinfection technology

New technology safely reduces viral spread in occupied spaces

Christie CounterAct_UV disinfection

Christie, the global visual and audio technology company, has announced that it will be mass-producing its new Christie CounterAct line of commercial UV disinfection products, which feature patented Care222 far-UVC light technology.

In the wake of COVID-19, safe ways of reducing viral spread are more important than ever and the CE and UL compliant CounterAct fixtures can be used in a range of occupied indoor spaces from cinemas, theme parks and museums to retail areas, sports complexes, restaurants, transit hubs and more.

Added layer of defence

CounterAct mounted fixtures use parent company Ushio Inc.’s Care222nm UV lamp technology, licensed through Columbia University, and are as straightforward to install as commercial lighting fixtures. They use proprietary filtered far-UVC light to eliminate 99% of pathogens on surfaces in indoor spaces, including the SARS-CoV-2 coronavirus, influenza, bacteria, and other antibiotic-resistant superbugs.

“With our CounterAct fixtures, as an added layer of defense, bringing customers back to the places they love to share and create memorable experiences, has never been safer,” says Brian Claypool, executive vice president, Cinema, Christie. “Many businesses and industries all over the world rely on being able to have their customers together in person, and they will need every tool available to help them do so safely.”

Safety compliant

Christie CounterAct

Christie CounterAct has been tested for compliance with UL, CE and UKCA by third-party testing facilities for electrical safety, electromagnetic compatibility (EMC), compliance with the radio equipment directive, and photobiological safety. Photobiological compliance is a safety evaluation to confirm that the level of UV exposure for occupants is in line with accepted industry guidelines.

The far-UVC 222nm light emitted by the Care222 lamps within CounterAct fixtures has been shown to be safe for use with people present, in a 2020 study by Kobe University. Care222 is the world’s first far-UVC technology with a proprietary optical filter that blocks potentially harmful longer (>230nm) UVC wavelengths from being emitted

“The fact that the unique far-UVC light from our Christie CounterAct UVC disinfection fixtures can be used automatically and continually in the presence of people is the key advantage. The technology reduces pathogens from the environments where people gather,” says Claypool.

“By harnessing these benefits as part of a user-friendly product that can be quickly deployed, we hope to provide a much-needed boost to our partners across many industries.”

Earlier this week, Christie also announced that it has provided its Christie Spyder X80 multi-windowing processor to Worre Studios, a new immersive virtual event space in Las Vegas. 

Share this
charlotte coates

Charlotte Coates

Charlotte Coates is blooloop's editor. She is from Brighton, UK and previously worked as a librarian. She has a strong interest in arts, culture and information and graduated from the University of Sussex with a degree in English Literature. Charlotte can usually be found either with her head in a book or planning her next travel adventure.

More from this author

Companies featured in this post

More from this author

Related content

Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Find out how to update